Background: Glucocorticoids (GCs) are the cornerstone of polymyalgia rheumatica (PMR)
therapy, but their long-term use (as is usually necessary in PMR patients) can induce many …

Polymyalgia rheumatica is effectively treated with glucocorticoids. However, glucocorticoid
treatment can cause numerous and potentially serious side effects. Therefore, lowest …

Glucocorticoids are the mainstay of treatment for patients with polymyalgia rheumatica
(PMR) and often produce substantial clinical improvements, but treatment can be …

Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …

Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder of unknown cause
characterised by the subacute onset of shoulder and pelvic girdle pain, and early morning …

To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia
rheumatica (PMR). A systematic literature review was conducted using Ovid Medline …

Background Treatment of Polymyalgia rheumatica (PMR) is subject to wide variations in
clinical practice. We are currently developing new management guidelines for PMR for …

Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

Introduction To elucidate in polymyalgia rheumatica (PMR) the role of tumor necrosis factor
(TNF) α and the therapeutic potential of blockade with soluble TNF-α receptor, we carried …

Background: Treatment of polymyalgia rheumatica (PMR) can be challenging. The most
efficacious and cost-effective treatment of PMR is some type of glucocorticoid (GC), with …